1997
DOI: 10.1016/s0140-6736(97)26047-2
|View full text |Cite
|
Sign up to set email alerts
|

Ethics of HIV trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

1998
1998
2020
2020

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 3 publications
0
4
0
Order By: Relevance
“…First, biomedical codes of conduct have not eliminated exploitation. Deficient global jurisdiction (Benatar, 2002; Nicoll, 1999) creates loopholes (Angell, 1997; Nuffield Council on Bioethics, 1999, 2002), especially in developing countries: Informed consent, for instance, has not been deemed necessary in countries that have an absence of codes (Aaby et al, 1997; Connor et al, 1994; Lurie & Wolfe, 1997).…”
Section: Discussionmentioning
confidence: 99%
“…First, biomedical codes of conduct have not eliminated exploitation. Deficient global jurisdiction (Benatar, 2002; Nicoll, 1999) creates loopholes (Angell, 1997; Nuffield Council on Bioethics, 1999, 2002), especially in developing countries: Informed consent, for instance, has not been deemed necessary in countries that have an absence of codes (Aaby et al, 1997; Connor et al, 1994; Lurie & Wolfe, 1997).…”
Section: Discussionmentioning
confidence: 99%
“…14 However, the standardisation would have inhibited HIV research in Africa and was opposed by global health researchers. 15 This enabled the research to be conducted quickly and at relatively low cost, and research on the prevention and management of diabetes and hypertension may need similar considerations. Thus, although not ideal, priority of medicines for research subjects will be essential in some settings where the supply of medicines cannot be strengthened for all.…”
Section: Is There An Obligation To Provide Medicines To Non-trial Parmentioning
confidence: 99%
“…The globalization of biomedical research -purportedly guided by ethical principles established in developed countries -has led to numerous controversies and ethical dilemmas [7]. For example, the use of placebo controls in clinical trials for preventing perinatal HIV transmission provoked an intense debate concerning issues of research design, exploitation and fairness, and the relationship between a clinical investigator and a human subject [7][8][9]. This debate involved not only procedural and regulatory questions, such as those related to implementing research protocols or documenting consent, but also deeper questions concerning the social, cultural, and philosophical foundations of research.…”
Section: Introductionmentioning
confidence: 99%